Operating Margin

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

The research giant took a massive Q4 loss from asset impairments but points to improving client demand and a strategic overhaul as signs of a turnaround.

Polestar unveils a bold plan to launch four new models by 2028, but can the EV maker overcome financial hurdles and intense market competition?

With an 11% dividend hike and 22 years of growth, ADI proves its stability while investing heavily in the future of AI, automotive, and healthcare.

New discoveries and record gold reserves at Ecuador's Fruta del Norte mine signal a golden future, extending its life and boosting investor confidence.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

An upcoming DC workshop highlights how public-private partnerships are modernizing federal facilities, saving energy, and bolstering national security.

With new Series A funding, Daffodil Health's AI platform aims to dismantle the opaque, costly systems that drive up U.S. healthcare spending.

A foodservice supplier's foundation marks one year by planting 373,000 trees and saving vital species, pioneering a new model for corporate responsibility.

Security giant Senstar finalizes its acquisition of 3D LiDAR innovator Blickfeld, a strategic move set to revolutionize security with smarter detection.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

A strategic merger creates a new aerospace and defense giant, but existing shareholders face significant dilution in a deal laden with both promise and risk.

Forget simple indicators. A new breed of retail trader uses complex data, automation, and strict risk rules to gain a professional edge in the market.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

Ahead of a key industry conference, the food giant reaffirms its 2026 guidance and boosts its cash flow forecast, signaling strong operational health.

With 15+ years on the front lines, new DOMAC leader Monica Trimble plans to elevate the role of dental office managers through national certification.

UGG's Spring 2026 campaign, fronted by global icons Central Cee and Su Yiming, introduces new clogs and mules in a bold move to redefine menswear.